Abbott prevails on patent term extension for stent

Online wsj noted:

Abbott is seeking to extend the patent until May 24, 2011, to account for time it took to research and win approval for its Xience stent, a tiny mesh scaffold used to prop open clogged arteries that went on sale in July. A review by the patent office, which announced the extension in a decision published Tuesday [Oct. 14], is continuing.

In a case in California, Medtronic had attempted to block the impact of the extension on an injunction against Medtronic.


See also
http://ipbiz.blogspot.com/2008/10/wyeth-v-dudas-on-patent-term.html